Ectodermal dysplasia syndrome is a complex group of genetic disorders identified by the abnormal development of the ectodermal structures. The aim of this retrospective clinical case series report was to evaluate the outcomes of the ectodermal dysplasia syndrome patients that underwent zygomatic implant surgery. Materials and Methods: A total of 9 ectodermal dysplasia syndrome patients aged between 21 and 56 years (mean age 36.8) with severely atrophic maxilla were included in this study. All the patients were treated with a total of 19 zygomatic implants. The mean follow-up of the patients was 55 months (with a range of 44–84 months). The implant survival rate was evaluated as a primary outcome. The intra- and postoperative complications were evaluated as additional criteria for success. Results: The overall implant survival rate was 100% without any complications. Final or provisional prosthesis was delivered on the same day of surgery, which resulted in an improvement of the quality of life of the patients. Conclusion: According to the results of this study, zygomatic surgery can be considered as a viable and safe alternative to conventional treatment modalities for oral rehabilitation of ectodermal dysplasia syndrome patients.

Zygomatic Implant Survival in 9 Ectodermal Dysplasia Patients with 3.5 to 7-year Follow Up / F. Goker, E. Grecchi, E.G. Mancini, M. Del Fabbro, F. Grecchi. - In: ORAL DISEASES. - ISSN 1354-523X. - (2020). [Epub ahead of print] [10.1111/odi.13505]

Zygomatic Implant Survival in 9 Ectodermal Dysplasia Patients with 3.5 to 7-year Follow Up

F. Goker
Primo
;
E. Grecchi
Secondo
;
M. Del Fabbro
Penultimo
;
2020

Abstract

Ectodermal dysplasia syndrome is a complex group of genetic disorders identified by the abnormal development of the ectodermal structures. The aim of this retrospective clinical case series report was to evaluate the outcomes of the ectodermal dysplasia syndrome patients that underwent zygomatic implant surgery. Materials and Methods: A total of 9 ectodermal dysplasia syndrome patients aged between 21 and 56 years (mean age 36.8) with severely atrophic maxilla were included in this study. All the patients were treated with a total of 19 zygomatic implants. The mean follow-up of the patients was 55 months (with a range of 44–84 months). The implant survival rate was evaluated as a primary outcome. The intra- and postoperative complications were evaluated as additional criteria for success. Results: The overall implant survival rate was 100% without any complications. Final or provisional prosthesis was delivered on the same day of surgery, which resulted in an improvement of the quality of life of the patients. Conclusion: According to the results of this study, zygomatic surgery can be considered as a viable and safe alternative to conventional treatment modalities for oral rehabilitation of ectodermal dysplasia syndrome patients.
Zygomatic implants; atrophic maxilla; bone atrophy; dental implants; ectodermal dysplasia syndrome; oral rehabilitation
Settore MED/28 - Malattie Odontostomatologiche
Settore MED/29 - Chirurgia Maxillofacciale
Settore MED/50 - Scienze Tecniche Mediche Applicate
24-giu-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
OD 2020 Goker zygomatic in ectoderma dysplasia.pdf

accesso aperto

Tipologia: Pre-print (manoscritto inviato all'editore)
Dimensione 3.35 MB
Formato Adobe PDF
3.35 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/744821
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 4
social impact